EDIT EBITDA Growth
Editas Medicine Inc · EBITDA Growth
EDIT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported67.32%period ending
EDIT TTM EBITDA YoY % (-173.57% → 67.32%)
Year-over-year change
High-resolution chart · PNG
EDIT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 67.3152% | |
| 56.7978% | |
| 32.5258% | |
| 13.8584% | |
| -14.5048% | |
| -44.6056% | |
| -49.6721% | |
| -8.348% | |
| 5.9561% | |
| 24.656% | |
| 31.2665% | |
| 3.054% | |
| -11.698% | |
| -17.5784% | |
| -14.1207% | |
| 8.2447% | |
| -8.6683% | |
| -28.4555% | |
| -43.3416% | |
| -102.5832% | |
| -10.4801% | |
| 8.1514% | |
| 5.2226% | |
| 16.0178% | |
| -39.8611% | |
| -38.9632% | |
| -24.9998% | |
| -3.5265% | |
| 18.9273% | |
| 6.3747% | |
| 5.5762% | |
| -0.4298% | |
| -14.2268% | |
| -8.715% | |
| -21.8452% | |
| -72.2097% | |
| -104.8376% | |
| -128.5458% | |
| -174.8168% | |
| -148.5915% | |
| -134.8352% | |
| -200.6468% | |
| -173.5672% |